EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H33FN4O3S |
| Net Charge | 0 |
| Average Mass | 500.640 |
| Monoisotopic Mass | 500.22574 |
| SMILES | [H][C@@]1(c2nc(C(=O)c3ccc(F)cc3)cs2)CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1 |
| InChI | InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1 |
| InChIKey | UFPFGVNKHCLJJO-SSKFGXFMSA-N |
| Roles Classification |
|---|
| Biological Role: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| LCL161 (CHEBI:193137) has role antineoplastic agent (CHEBI:35610) |
| LCL161 (CHEBI:193137) has role apoptosis inducer (CHEBI:68495) |
| LCL161 (CHEBI:193137) is a N-acylpyrrolidine (CHEBI:46766) |
| LCL161 (CHEBI:193137) is a L-alanine derivative (CHEBI:83943) |
| LCL161 (CHEBI:193137) is a 1,3-thiazoles (CHEBI:38418) |
| LCL161 (CHEBI:193137) is a aromatic ketone (CHEBI:76224) |
| LCL161 (CHEBI:193137) is a monofluorobenzenes (CHEBI:83575) |
| IUPAC Name |
|---|
| N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N2-methyl-L-alaninamide |
| Synonyms | Source |
|---|---|
| LCL 161 | ChEBI |
| (2S)-N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-2-(methylamino)propanamide | IUPAC |
| LCL-161 | SUBMITTER |
| NVP-LCL161 | ChEBI |
| (S)-N-((S)-1-cyclohexyl-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:1005342-46-0 | SUBMITTER |
| Citations |
|---|